SlimTarget Medical

Company Overview

Snapshot

Founded in January 2021, SlimTarget Medical operates with 1–10 employees. The company has secured funding across one round from Israel MedicUp to advance its medical device technology.

Business overview

SlimTarget Medical develops medical devices leveraging focused ultrasound technology to address weight loss in overweight patients, particularly those with chronic conditions like diabetes and high blood pressure. The company's core technology involves an MRI-guided, non-invasive focused ultrasound treatment designed to ablate a specific brain point associated with increased appetite. This procedure aims to provide a precise, painless, and long-term alternative to bariatric surgery, reducing associated complications and treatment costs. SlimTarget Medical operates within the Health Tech & Life Sciences sector, specifically targeting the Medical Devices industry and patients seeking non-invasive therapeutic solutions.

Company Intelligence Q&A

What is SlimTarget Medical's primary focus?

SlimTarget Medical focuses on developing a focused ultrasound-based treatment for weight loss in overweight patients, particularly those with chronic conditions such as diabetes and high blood pressure.

When was SlimTarget Medical founded?

SlimTarget Medical was founded in January 2021.

What technology does SlimTarget Medical utilize?

SlimTarget Medical utilizes MRI-guided focused ultrasound technology to perform delicate ablation procedures on a specific brain point linked to appetite regulation.

What is the goal of SlimTarget Medical's treatment?

The treatment aims to reduce appetite and achieve weight loss, offering a non-invasive, precise, and long-term alternative to bariatric surgery, thereby reducing complications and treatment costs.